While useful in analyzing population trends in relative body weight, BMI possesses multiple shortcomings when used as an individualized health screening tool.
AMA J Ethics. 2023; 25(7):E545-549. doi:
10.1001/amajethics.2023.545.
Dr Chloë G. K. Atkins joins Ethics Talk to discuss her article, coauthored with Dr Sunit Das: “What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions?”
Clinicians can support shared decision making by assessing patients’ knowledge, eligibility for screening, and preferences for engagement—active, collaborative, or passive—in the decision making process.
AMA J Ethics. 2015; 17(7):601-607. doi:
10.1001/journalofethics.2015.17.7.ecas1-1507.
Although effective, opioid agonist therapy is associated with stigma and thus underutilized for treatment of opioid use disorder in incarcerated settings.
AMA J Ethics. 2017; 19(9):922-930. doi:
10.1001/journalofethics.2017.19.9.stas1-1709.
Joel A. DeLisa, MD, MS and Jacob Jay Lindenthal, PhD, DrPH
Research on experiences of practicing physicians who have disabilities could help medical schools counsel applicants and increase enrollment among students with disabilities. This can ultimately improve care for patients with disabilities.
AMA J Ethics. 2016; 18(10):1003-1009. doi:
10.1001/journalofethics.2016.18.10.stas1-1610.